Is penicillin and/or erythromycin resistance present in clinical isolates of group B streptococcus in our community?

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 42, Issue 5, 2002, Pages 543-544

  Stylianopoulos, Anastasia ^a   Kelly, Nigel ^a   Garland, Suzanne ^a  

^a ROYAL WOMEN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIAL INFECTION; BACTERIUM ISOLATE; CHEMOPROPHYLAXIS; CLINICAL STUDY; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEWBORN INFECTION; NORTH AMERICA; PERINATAL PERIOD; POPULATION RESEARCH; PRIORITY JOURNAL; STREPTOCOCCUS AGALACTIAE;

ANTI-BACTERIAL AGENTS; AUSTRALIA; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ERYTHROMYCIN; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PREGNANCY; STREPTOCOCCUS AGALACTIAE; VAGINA; VANCOMYCIN RESISTANCE;

EID: 0036855523     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0004-8666.2002.00543.x     Document Type: Article

References (12)

1. Edwards MS, Baker CJ. Group B streptococcal infections. In: Remington TA, Klein JO, eds. Infectious Diseases of the fetus and newborn. 5th ed Philadelphia: WB Saunders, 2001: 1091-1156.
2. Garland SM. Early onset neonatal group B streptococcus (GBS) infection: associated obstetric factors. Aust N Z J Obstet Gynaecol. 1991 May; 31 (2): 117-118.
3. Prevention of perinatal group B streptococal disease: a public health perspective. Centers for Disease Control and Prevention. MMWR Recomm Rep. 1996 May 31; 45 (RR-7): 1-24.
4. Garland SM, Kelly N. Early-onset neonatal group B streptococcal sepsis: economics of various prevention strategies. Med J Aust. 1995 Apr; 162 (8): 413-417.
5. Fliegner JR, Garland SM. Perinatal mortality in Victoria, Australia: role of group B streptococcus. Am J Obstet Gynecol. 1990 Nov; 163 (5 Pt 1): 1609-1611.
6. Pearlman MD, Pierson CL, Faix RG. Frequent resistance of clinical group B streptococci to clindamycin and erythromycin. Obstet Gynecol. 1998 Aug; 92 (2): 258-261.
7. Uh Y, Jang IH, Yoon KJ, Lee CH, Kwon JY, Kim MC. Colonization rates and serotypes of group B streptococci isolated from pregnant women in a Korean tertiary hospital. Eur J Clin Microbiol Infect Dis. 1997 Oct; 16 (10): 153-156.
8. Morales WJ, Dickey SS, Bornick P, Lim DV. Change in antibiotic resistance of group B streptococcus: impact on intrapartum management. Am J Obstet Gynecol. 1999 Aug; 181 (2): 310-314.
9. Kelly VN, Garland SM. Evaluation of new Granada medium (modified) for the antenatal screening of group B streptococcus. Pathology. 1994 Oct; 26 (4): 487-489.
10. NCCLS Performance Standards for Antimicrobial Susceptibility Tests; Approved Standard - Sixth Edition, M2-A6. NCCLS Wayne, 1997; Vol 17 No 1.
11. Lin FY, Azimi PH, Weisman LE, Philips JB 3rd, Regan J, Clark P, Rhoads GG, Clemens J, Troendle J, Pratt E, Brenner RA, Gill V. Antibiotic susceptibility profiles for group B streptococci isolated from neonates, 1995-1998. Clin Infect Dis. 2000 Jul; 31 (1): 76-79.
12. de Azavedo JC, MeGavin M, Duncan C, Low DE, McGeer A. Prevalence and mechanism of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 2001 Dec; 45 (12): 3504-3508.